Phase I Study of VLPDEN-02 Dengue Vaccine in Healthy Adults
NCT07831473
Arbovirus Infections, Challenge Test
Baltimore, Maryland, United States
View Trial DetailsNCT Number: NCT07203183
The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.
Trial opening soon.
Get Notified12 year and older
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 months
Trial opening soon.
Get NotifiedAbbott Rapid Dx
Industry
A Prospective Study for the Collection of Whole Blood Samples to Support the Development and Validation of In Vitro Diagnostic Tests for Dengue
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07831473
Arbovirus Infections, Challenge Test
Baltimore, Maryland, United States
View Trial DetailsNCT07799168
Arbovirus Infections, Dengue
Nha Trang, Vietnam
View Trial DetailsNCT06973772
Alphavirus Infections, Arbovirus Infections
Curitiba, Paraná, Brazil
View Trial DetailsNCT07600879
Alphavirus Infections, Arbovirus Infections
Belém, Pará, Brazil
View Trial Details